Gurnet Point Capital
Gurnet Point Capital is a healthcare investment firm based in Cambridge, MA, focused on investing in scientifically de-risked life sciences companies. Founded in 2015, the firm employs an active ownership strategy to drive value creation through its financial capabilities, technical knowledge, and operational improvements. Gurnet Point Capital aims to bring safe and effective treatments to market, positively impacting patient outcomes and generating significant returns for investors.
Gurnet Point Capital
55 Cambridge Parkway, Suite 401, Cambridge, MA 02142
What We Do
Gurnet Point Capital employs an active ownership approach, taking control positions to apply the skills and experience of its investment and operations team to efficiently move portfolio companies through key value inflection points.
The firm leverages its technical, commercial, and operational expertise to advance the standard of care for patients and improve population health.
Portfolio
Paratek Pharmaceuticals is focused on the development and commercialization of novel therapies for life-threatening diseases and other public health threats. The company's lead product, NUZYRA, is an antibiotic for treating community-acquired bacterial pneumonia and acute bacterial skin infections.
#Biopharmaceutical
Corium Innovations specializes in novel drug delivery technologies, including transdermal modalities. It is a full-service contract development and manufacturing organization.
#Pharmaceutical
Radius Health focuses on addressing unmet medical needs in bone health. Its lead product, TYMLOS, is used for treating postmenopausal women with osteoporosis.
#Biopharmaceutical
Naveris develops and commercializes blood tests for managing viral-associated cancers.
#Diagnostics
Crossover Health provides healthcare services for self-insured employers, integrating primary care with digital health solutions.
#Healthcare Services
Auregen BioTherapeutics is a biotechnology company translating pioneering 3D bioprinting technology for innovative treatments for patients with rare disorders.
#Biotechnology
Innocoll Holdings is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet significant unmet medical needs.
#Pharmaceutical